We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Immune Pharmaceuticals Licenses a Novel Bispecific Antibody Technology

News   Dec 29, 2015

 
Immune Pharmaceuticals Licenses a Novel Bispecific Antibody Technology
 
 
 

RELATED ARTICLES

Blood Circulation Disorder Could Be an Autoimmune Disease

News

In a patient-based study, researchers have found evidence to suggest postural orthostatic tachycardia syndrome (POTS) could be an autoimmune disease.

READ MORE

Molecule Helps Stressed Cells Decide Between Life and Death

News

a molecule that plays a pivotal role in determining the fate of cells under stress, much like a Roman emperor deciding the fate of gladiators in the coliseum. The findings appear today in the journal Nature and suggest a possible new approach for treatment of autoinflammatory and other diseases.

READ MORE

First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment

News

In a world first, researchers from Penn Medicine have used genetically modified T cells to target and ablate fibroblasts that contribute to the development of heart disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE